atopic dermatitis Archives -

Lilly swoops on Dermira to claim Dupixent rival

https://pharmaphorum.com/news/lilly-swoops-on-dermira-to-claim-dupixent-rival/

Novartis’ $100m bet on eczema drug fails as MOR106 development ends

https://pharmaphorum.com/news/novartis-100m-bet-on-eczema-drug-fails-as-mor106-development-ends/

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

https://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/

Sanofi’s eczema drug gets EU approval to treat adolescents

https://pharmaphorum.com/news/sanofi-eczema-drug-gets-eu-approval-adolescents/

Almirall takes option on Dermira’s eczema drug lebrikizumab

https://pharmaphorum.com/news/almirall-takes-option-on-dermiras-eczema-drug-lebrikizumab/

Almirall signs atopic dermatitis R&D deal with Hitgen

https://pharmaphorum.com/news/almirall-signs-atopic-dermatitis-rd-deal-with-hitgen/

NICE okays NHS funding for MS and eczema drugs

https://pharmaphorum.com/news/nice-okays-nhs-funding-for-ms-and-eczema-drugs/

Sanofi’s blockbuster-tipped Dupixent set for European launches

https://pharmaphorum.com/news/sanofis-blockbuster-tipped-dupixent-set-european-launches/

Sanofi’s dermatitis drug dupilumab fast-tracked by FDA

https://pharmaphorum.com/news/sanofis-dermatitis-drug-dupilumab-fast-tracked-fda/

Search